ArticleFrontiers in nutrition2025
Atherosclerosis index and BMI: new predictors of cognitive function in ischemic survivors.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The atherogenic index of plasma (AIP) is a reliable surrogate marker for insulin resistance and is strongly associated with both stroke risk and prognosis. However, the associations of AIP and the composite index AIP-BMI with cognitive function among patients with ischemic stroke remain insufficiently studied. Methods: This cross-sectional study included 2,933 patients with ischemic stroke. Demographic and clinical data were collected from all participants. The AIP was calculated as log [TG (mmol/L)/HDL-C (mmol/L)], and cognitive function was evaluated using the Mini-Mental State Examination (MMSE). Multivariable linear regression models were applied to examine the associations between AIP (and AIP-BMI) and MMSE scores, adjusting for potential confounders. Stratified and sensitivity analyses were further conducted to evaluate the robustness of the findings. Results: The mean age of participants was 64.8 years (SD 10.2), and 2,009 (68.5%) were male. Each one-unit increase in AIP was associated with a 1.15-point reduction in MMSE score ( Conclusion: Higher levels of AIP and AIP-BMI are independently associated with poorer cognitive performance in patients with ischemic stroke. These findings suggest that dyslipidemia-related metabolic disturbances may contribute to post-stroke cognitive impairment. Clinical trial registration: https://www.chictr.org.cn/showproj.html?proj=120858, identifier ChiCTR2100042721.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.